Reduce the effort needed to integrate, explore and preserve your data
We provide advice, open source platforms and training to translational research projects.
eTRIKS is an IMI project that is funded to support other projects. If you know of a project that eTRIKS could support contact us here.
eTRIKS is supporting 27 projects
and we want to support 40 by the end of 2017
We have trained over 300 researchers
Find out more about training opportunities
We make data curation faster and data exploration easier
Help us create new tools in eTRIKS Labs
"eTRIKS provides the gel, without which we would be floating in excess pools of data."
Ian Adcock - U-BIOPRED Work Package 6 leader
eTRIKS Standards Starter Pack is in use broadly throughout the IMI
Get the eTRIKS starter pack here
New eTRIKS LAB established -
HiDomeCreate patient cohorts by setting constraints on components in high dimensional data sets.
Show your commitment to responsible management of medical research data
Portfolio of Resources
Analysis pipelines for very rich data sets The Challenge OncoTrack is looking at deep data sets for cancer patients to discover new markers for Colon Cancer. The goal of OncoTrack is to identify and characterize biomarkers that will help our understanding of the variable make-up of tumours and how this affects the way patients respond to treatment. This can be used to guide appropriate therapy choices for each individual patient. The data sets created are extremely rich containing clinical data, animal xenograft data and a wide range of genomic information including GWAS and NGS. Already hundreds of terabytes of data […]
- September 3, 2015
- View website
Unbiased comparison of data sets The Challenge Severe Asthma is often difficult to manage and many patients are unresponsive to treatment. Furthermore, it is thought that there are many different phenotypes of asthma that are not properly understood. U-BIOPRED aims to create ‘handprints’ that identify sub-phenotypes of asthma. The handprints can then be used to better understand the disease and lead to better targeted treatments for the individual. U-BIOPRED handprints include a wealth of diverse data on each patient and the researchers need to compare and combine them in an unbiased environment. This will permit identification of a wide range […]
- September 1, 2015
- View website
Comparing clinical data across multiple disease areas The Challenge Biopharmaceuticals provide a valuable new approach to disease management. But a significant limitation in their use is the development of anti-drug antibodies (ADA) in some patients. The development of ADA is seen to some extent across all diseases and with all treatments, but the individual data sets for any single disease and treatment have usually been small. ABIRISK seeks to bring these data sets together to understand the common underlying causes of ADA. To do this, disparate data sets from multiple disease areas and many different institutions need to be analysed […]
- September 4, 2015
- View website